(ASIX) AdvanSix - NYSE
Sector: Basic Materials | Industry: Chemicals | Exchange: NYSE (USA) | Market Cap: 584m USD | Total Return: -2.6% in 12m
Avg Turnover: 4.56M
EPS Trend: -5.6%
Qual. Beats: 0
Rev. Trend: -40.6%
Qual. Beats: 0
Warnings
High Debt/EBITDA (6.0) with thin interest coverage (1.4)
High Debt while negative Cash Flow
Tailwinds
No distinct edge detected
AdvanSix Inc. (ASIX) is an integrated manufacturer of polymer resins and chemical intermediates based in the United States. The company’s core production focuses on Nylon 6, a synthetic material essential for engineered plastics, fibers, and films. Its portfolio extends to essential co-products, including caprolactam, ammonium sulfate fertilizers for the agricultural sector, and acetone used in industrial solvents and coatings.
Operating within the commodity chemicals sub-industry, AdvanSix utilizes a highly integrated manufacturing chain where the output of one process often serves as the feedstock for another, enhancing cost efficiencies. The company serves diverse end markets ranging from automotive and pharmaceuticals to water treatment and commercial agriculture. For a more granular look at these financial drivers, consider exploring the data available on ValueRay.
AdvanSix markets its products under established brands such as Aegis, Sulf-N, and Nadone, utilizing both direct sales forces and third-party distributors to reach international markets. This business model relies heavily on global demand cycles for nylon and the seasonal nature of the fertilizer industry.
- Spreads between raw material benzene and finished caprolactam prices dictate core profitability
- Global ammonium sulfate demand and fertilizer pricing cycles drive seasonal revenue volatility
- Domestic acetone supply-demand balance and anti-dumping duties influence chemical segment margins
- Planned and unplanned maintenance turnouts at Hopewell facility impact operational throughput
- Fluctuations in automotive and construction demand affect Nylon 6 resin sales volumes
| Net Income: 10.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -4.42 > 1.0 |
| NWC/Revenue: 5.40% < 20% (prev 4.31%; Δ 1.08% < -1%) |
| CFO/TA 0.06 > 3% & CFO 96.1m > Net Income 10.4m |
| Net Debt (565.1m) to EBITDA (94.4m): 5.98 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.0m) vs 12m ago -1.13% < -2% |
| Gross Margin: 7.44% > 18% (prev 13.05%; Δ -5.61% > 0.5%) |
| Asset Turnover: 92.82% > 50% (prev 95.85%; Δ -3.03% > 0%) |
| Interest Coverage Ratio: 1.38 > 6 (EBIT TTM 12.9m / Interest Expense TTM 9.37m) |
| A: 0.05 (Total Current Assets 454.0m - Total Current Liabilities 370.4m) / Total Assets 1.71b |
| B: 0.38 (Retained Earnings 642.9m / Total Assets 1.71b) |
| C: 0.01 (EBIT TTM 12.9m / Avg Total Assets 1.67b) |
| D: 0.87 (Book Value of Equity 796.3m / Total Liabilities 914.5m) |
| Altman-Z'' = 2.51 = A |
| DSRI: 1.29 (Receivables 229.7m/179.3m, Revenue 1.55b/1.56b) |
| GMI: 1.75 (GM 13.05% / 7.44%) |
| AQI: 0.95 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 0.99 (Revenue 1.55b / 1.56b) |
| TATA: -0.05 (NI 10.4m - CFO 96.1m) / TA 1.71b) |
| Beneish M = -2.15 (Cap -4..+1) = BB |
As of June 15, 2026, the stock is trading at USD 22.81 with a total of 148,794 shares traded.
Over the past week, the price has changed by +6.19%,
over one month by +5.36%,
over three months by +13.19% and
over the past year by -2.62%.
AdvanSix has no consensus analysts rating.
| Analysts Target Price | 23.5 | 3% |
P/E Trailing = 60.125
P/S = 0.3768
P/B = 0.7279
Revenue TTM = 1.55b USD
EBIT TTM = 12.9m USD
EBITDA TTM = 94.4m USD
Long Term Debt = 270.0m USD (from longTermDebt, last quarter)
Short Term Debt = 43.7m USD (from shortTermDebt, last quarter)
Debt = 582.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 156.4m
Net Debt = 565.1m USD (calculated: Debt 582.7m - CCE 17.6m)
Enterprise Value = 1.15b USD (583.5m + Debt 582.7m - CCE 17.6m)
Interest Coverage Ratio = 1.38 (Ebit TTM 12.9m / Interest Expense TTM 9.37m)
EV/FCF = -51.67x (Enterprise Value 1.15b / FCF TTM -22.2m)
FCF Yield = -1.94% (FCF TTM -22.2m / Enterprise Value 1.15b)
FCF Margin = -1.44% (FCF TTM -22.2m / Revenue TTM 1.55b)
Net Margin = 0.67% (Net Income TTM 10.4m / Revenue TTM 1.55b)
Gross Margin = 7.44% ((Revenue TTM 1.55b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = 0.94% (prev 7.60%)
Tobins Q-Ratio = 0.67 (Enterprise Value 1.15b / Total Assets 1.71b)
Interest Expense / Debt = 1.61% (Interest Expense 9.37m / Debt 582.7m)
Taxrate = 9.45% (5.14m / 54.4m)
NOPAT = 11.7m (EBIT 12.9m * (1 - 9.45%))
Current Ratio = 1.23 (Total Current Assets 454.0m / Total Current Liabilities 370.4m)
Debt / Equity = 0.73 (Debt 582.7m / totalStockholderEquity, last quarter 796.3m)
Debt / EBITDA = 5.98 (Net Debt 565.1m / EBITDA 94.4m)
Debt / FCF = -25.42 (negative FCF - burning cash) (Net Debt 565.1m / FCF TTM -22.2m)
Total Stockholder Equity = 813.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.62% (Net Income 10.4m / Total Assets 1.71b)
RoE = 1.28% (Net Income TTM 10.4m / Total Stockholder Equity 813.4m)
RoCE = 1.19% (EBIT 12.9m / Capital Employed (Equity 813.4m + L.T.Debt 270.0m))
RoIC = 0.86% (NOPAT 11.7m / Invested Capital 1.37b)
WACC = 5.20% (E(583.5m)/V(1.17b) * Re(8.94%) + D(582.7m)/V(1.17b) * Rd(1.61%) * (1-Tc(0.09)))
Discount Rate = 8.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 28.89 | Cagr: 0.11%
[DCF] Fair Price = unknown (Cash Flow -22.2m)
EPS Correlation: -5.61 | EPS CAGR: -5.29% | SUE: -0.13 | # QB: 0
Revenue Correlation: -40.63 | Revenue CAGR: -1.73% | SUE: 0.07 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.56 | Chg30d=-11.90% | Revisions=+20% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.42 | Chg30d=+8.97% | Revisions=+20% | Analysts=2
EPS current Year (2026-12-31): EPS=1.44 | Chg30d=-5.90% | Revisions=+0% | GrowthEPS=-37.1% | GrowthRev=+10.8%
EPS next Year (2027-12-31): EPS=2.92 | Chg30d=+2.99% | Revisions=N/A | GrowthEPS=+103.8% | GrowthRev=+5.1%
[Analyst] Revisions Ratio: +20%